President Donald Trump had to be begged not to spill the beans about a seismic change to U.S. drug policy which was made this month, according to a report from the Wall Street Journal published on Saturday. After extensive lobbying and some generous donations from major players in the marijuana industry, the president was convinced to follow through with his campaign promise to shift cannabis from a Schedule I to Schedule III substance during a meeting with Kim Rivers, the CEO of Florida-based cannabis company Trulieve, Trump confidante Howard Kessler and Florida Sheriff Gordon Smith in early December. Politics: Jordan Klepper Shares 1 Way MAGA Has Changed Since Trump's First TermEager to share the news immediately, Trump told the people in the room he planned to announce the decision on Truth Social before an executive order was even drafted. Advertisement AdvertisementAdvertisement AdvertisementSmith remembered things getting heated as Oval Office insiders tried to stop their boss from blabbing, according to the Journal. President Donald Trump pictured after signing an executive order reclassifying marijuana as a schedule III drug on December 18, 2025.

Source: Huffington Post December 29, 2025 00:23 UTC